Tango Therapeutics, Inc. ($TNGX)
Filing Information
| Accession Number | 0001193125-26-295124 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 2, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
81,000
Total Value
$939,308.18
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
President, R&D | Common Stock | โ | Jul 1, 2026 | Exercise/Conversion | 27,000 | $5.20 | $140,400.00 | 142,743 | Direct | โ | View Details | |
President, R&D | Common Stock | โ | Jul 1, 2026 | Sale | 19,629 | $29.34 | $575,961.97 | 123,114 | Direct | โ | View Details | |
President, R&D | Common Stock | โ | Jul 1, 2026 | Sale | 7,371 | $30.25 | $222,946.21 | 115,743 | Direct | โ | View Details | |
President, R&D | Stock Option (Right to Buy) | Derivative | Jul 1, 2026 | Exercise/Conversion | 27,000 | $0.00 | $0.00 | 314,040 | Direct | โ | View Details |